General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a white pills imageFebruary 14 2018

GPs have increased long-term opioid prescribing for non-cancer pain against guidelines, an observational study has found. 

Analysis of prescription data for all opioids indicates the amounts prescribed has increased, and that there are regional variations. “More opioids were prescribed in the north than in the south of England, and more opioids were prescribed in areas of greater social deprivation,” the University of London researchers found. Nine out of ten of the highest prescribing areas were located in the north of the country.

Data from England was analysed for prescribing of eight opioids from August 2010 to February 2014. “Over the 43-month study, an overall increase in opioid prescribing was found, specifically of buprenorphine, codeine, morphine, oxycodone, and tramadol, which was the most prescribed opioid in England,” said the researchers.

The study suggests an increase in tramadol prescribing has resulted from the withdrawal of co-proxamol in the mid-2000s, but also as it is an alternative to non-steroidal inflammatory drug analgesia. It also notes: “Many practitioners routinely prescribe opioids for chronic non-cancer pain because they believe it is unethical to withhold analgesia, regardless of the aetiology of pain, yet opioids are ineffective in much chronic pain beyond modest effects in the short term.”

Responding to the study, Professor Helen Stokes-Lampard, Chair of the Royal College of General Practitioners, said: “While some prescribed medication has been shown to be addictive, many of these drugs, when used appropriately and in conjunction with established clinical guidelines, are safe to use and can, most importantly, help relieve patients from debilitating and painful symptoms.

“Patients are also made aware of any potential risks and side effects of taking any new medication – regardless of whether it is a known addictive drug or not – and consulted about if they think it is right for them. Additionally, all medication newly issued to a patient should have an information leaflet provided by the dispensing pharmacist.”

While the study has demonstrated an increase in opioid prescribing for non-cancer pain, she said that “most patients don’t want to be on long-term prescriptions and, where possible, GPs will always try to explore non-pharmacological treatments.” However, “these are often hard to come by at a community level, leaving family doctors with few alternatives that are still of equal benefit to the patient.”

Prof Stoke-Lampard called on GPs and their teams to encourage patients to attend regular medication reviews and urged doctors to ensure “these drugs are only prescribed for the shortest amount of time, which is tailored to the individual.”

Links:
L Mordecai et al. ‘Patterns of regional variation of opioid prescribing in primary care in England: a retrospective observational study’. Br J Gen Pract. Published 12 February 2018.       
RCGP comment           

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...